Venetoclax-based salvage therapy as a bridge to transplant is feasible and effective in patients with relapsed/refractory AML
对于复发/难治性急性髓系白血病患者,以维奈托克为基础的挽救治疗作为移植桥梁是可行且有效的。
期刊:Blood Advances
影响因子:7.1
doi:10.1182/bloodadvances.2024013086
Unglaub, Julia M; Schlenk, Richard F; Middeke, Jan Moritz; Krause, Stefan W; Kraus, Sabrina; Einsele, Hermann; Kramer, Michael; Zukunft, Sven; Kauer, Joseph; Renders, Simon; Katelari, Elena; Schliemann, Christoph; Pabst, Caroline; Luft, Thomas; Dreger, Peter; Röllig, Christoph; Bornhäuser, Martin; Müller-Tidow, Carsten; Sauer, Tim